ORASURE TECHNOLOGIES, INC Business Combination, Acquisition Related Costs
ORASURE TECHNOLOGIES, INC (OSUR) reported Business Combination, Acquisition Related Costs of $343.00 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2020-08-06
- ORASURE TECHNOLOGIES, INC business combination, acquisition related costs for fiscal 2018 was $1.24B.
| Period end | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|
| 2020-06-30 | $343.00K 10-Q · filed 2020-08-06 | ||
| 2019-09-30 | $448.00K 10-Q · filed 2019-11-08 | ||
| 2018-12-31 | $1.24B 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |